"10.1371_journal.pone.0049726","plos one","2012-11-20T00:00:00Z","Bence Gy√∂rgy; Tam√°s G Szab√≥; Lilla Turi√°k; Matthew Wright; Petra Herczeg; Zsigmond L√©deczi; √Ågnes Kittel; Anna Polg√°r; K√°lm√°n T√≥th; Be√°ta D√©rfalvi; Gerg≈ë Zelen√°k; Istv√°n B√∂r√∂cz; Bob Carr; Gy√∂rgy Nagy; K√°roly V√©key; Steffen Gay; Andr√°s Falus; Edit I Buz√°s","Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary; Chemical Research Center of the Hungarian Academy of Sciences, Budapest, Hungary; NanoSight Ltd., Amesbury, United Kingdom; Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary; National Institute of Rheumatology and Physiotherapy, Budapest, Hungary; Department of Orthopaedics, University of Szeged, Szeged, Hungary; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Military Hospital, National Health Institute, Department of Orthopaedics, Budapest, Hungary; Department of Rheumatology, Semmelweis University, Budapest, Hungary; Center for Experimental Rheumatology, Zurich Center for Integrative Human Physiology, USZ, Zurich, Switzerland","Conceived and designed the experiments: BG KV EIB. Performed the experiments: BG TGS LT MW PH ZL √ÅK. Analyzed the data: AP KT BD GZ IB BG LT PH ZL EIB. Wrote the paper: BG EIB. Provided intellectual contributions to the manuscript: BG BC GN SG AF KV.","Bob Carr is the inventor of NanoSight technology and a co-founder of the NanoSight Ltd. company. Matthew Wright is an employee of NanoSight Ltd. This does not alter the authors‚Äô adherence to all the PLOS ONE policies on sharing data and materials. The authors declare no other competing interests.","2012","11","Bence Gy√∂rgy","BG√",18,TRUE,3,7,10,2,TRUE,TRUE,FALSE,0,NA,FALSE
